Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genzyme Biosurgery/Guidant

This article was originally published in The Gray Sheet

Executive Summary

Cross-license agreement between the firms covers certain patents for products used in "beating-heart" bypass procedures. Genzyme will make a one-time license fee payment to Guidant and pay ongoing royalties for sale of the products. Genzyme President Duke Collier said: "Access to Guidant's intellectual property provides us the opportunity to continue the success of our current off-pump line," which includes the Immobilizer...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts